ImmunityBio ($IBRX) Insider Trading & Smart Money Activity

ImmunityBio, Inc. · Biotechnology · Latest filing Oct 5, 2026

ImmunityBio, Inc. ($IBRX) has 3 insider trades and 2 congress trades on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($1.32M), net -$1.32M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
3
Net insider $ (12 mo)
-$1.32M
Congress trades (12 mo)
2
13F moves on file
0
Analyst ratings on file
0

IBRX insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $197K 0 / 0 0 / 0
Q3 2026 0 0 2 / 0 0 / 0
Q4 2026 0 2 · $1.12M 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All IBRX insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Simon Barry J.Director Sell (Open-market sale) 10b5-1 25K sh $268.76K -2.5% —
Insider Cohen CherylDirector Sell (Open-market sale) 10b5-1 81.06K sh $851.09K +2.1% —
Congress Lisa C. McClain Purchase $1,001 - $15,000 +3.3% Read
Congress Lisa C. McClain Purchase $1,001 - $15,000 +21.8% Read
Insider Barry Simon Sell (Open-market sale) 10b5-1 25K sh $197K +17.9%-9.0% Read

1W / 1M / 6M = how IBRX moved from the trade or filing date.

Insider trading in IBRX: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Simon Barry J. Director 1 -$268.76K Oct 5, 2026
Cohen Cheryl Director 1 -$851.09K Oct 2, 2026
Barry Simon 1 -$197K Jun 24, 2026

Members of Congress trading IBRX

Frequently asked questions

Are IBRX insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 3 open-market sales worth $1.32M, a net -$1.32M.

What is the latest insider trade in IBRX?

Simon Barry J., Director filed a sell (open-market sale) of 25K sh worth $268.76K on Oct 5, 2026.

Which members of Congress traded IBRX?

2 disclosed trades by Lisa C. McClain. The latest was on Sep 30, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text